Glaukos
GKOS
#2257
Rank
A$12.29 B
Marketcap
A$209.26
Share price
1.30%
Change (1 day)
35.27%
Change (1 year)

Earnings for Glaukos (GKOS)

Earnings in 2026 (TTM): -A$0.29 Billion

According to Glaukos's latest financial reports the company's current earnings are A$0.55 Billion. In 2025 the company made an earning of -A$0.28 Billion a decrease over its 2024 earnings that were of -A$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Glaukos from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.29 Billion3.83%
2025 -A$0.28 Billion38.98%
2024 -A$0.2 Billion12.88%
2023 -A$0.18 Billion41.77%
2022 -A$0.13 Billion135.99%
2021 -A$52.02 Million-69.63%
2020 -A$0.18 Billion148.99%
2019 -A$68.79 Million244.29%
2018 -A$19.98 Million-435.56%
2017 A$5.95 M-20.57%
2016 A$7.49 M-113.9%
2015 -A$53.95 Million182.83%
2014 -A$19.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ICU Medical
ICUI
A$0.14 B-151.44%๐Ÿ‡บ๐Ÿ‡ธ USA
AtriCure
ATRC
-A$6.21 Million-97.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Integra LifeSciences
IART
-A$0.65 Billion 134.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Hill-Rom
HRC
A$0.53 B-293.97%๐Ÿ‡บ๐Ÿ‡ธ USA